Taken together, this newly identified PLCG2 gene variant might display a new phenotype with clinical and laboratory overlap of PLAID and APLAID symptoms. Here, PLCG2 is linked to autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.